Idiopathic thrombocytopenic purpura: preliminary results in patients aged >65 years.
Sir,

Idiopathic thrombocytopenic purpura (ITP) is often diagnosed in the elderly, but no specific guidelines exist for such patients.1 Recent studies report that patient age may influence both therapeutic response and treatment-associated toxicity.2 We describe the preliminary results of our experience of ITP in a group of patients aged >65 years.

This retrospective study included 30 elderly patients (⩾65 years) followed since 1985 in the Departments of Internal Medicine, Geriatrics and Haematology of the University …